The company founder and President, Hashem Akhavan-Tafti, Ph.D., was formerly the Vice President of Research for Beckman Coulter’s Immunoassay and Molecular Diagnostics Business Group. Hashem managed a multi-disciplinary team of research scientists in the discovery of innovative detection technologies for clinical diagnostics and life science research applications and holds more than 80 issued patents in the United States.
AhuraTech’s CEO, Paul Glyer, has more than 30 years of experience in life sciences. Until 2011 he was a member of the Office of the President for Beckman Coulter, Inc., helping drive revenue growth from <$1B to nearly $4B through strategic M&A activity. While he held a variety of roles throughout his career, his last position was leading the Investor Relations, Business Development and Corporate Strategy functions. Paul is an executive advisor to Waterstreet Healthcare, a founding partner in IOI Partners, a strategy consultancy, and serves on the board of directors of Orgentec Diagnostika, a German provider of global testing solutions focused on autoimmune disease. He obtained an executive MBA from Claremont Graduate University and is a Chartered Financial Analyst.